India's drug regulator approves study on mixing of Covaxin, Covishield
India's drug regulator has given approval
for a study to be conducted by the Christian Medical College (CMC), Vellore on
mixing of COVID-19
vaccines Covaxin and Covishield, official sources said on
Wednesday.
An expert panel of the Central Drugs
Standard Control Organisation (CDSCO) on July 29 had recommended granting
permission for conducting the study.
The trial will involve 300 healthy
volunteers.
"The aim of the study is to assess
the feasibility on whether a person can be given two different vaccine shots --
one each of Covishield and Covaxin -- to complete the inoculation course,"
a source said.
Separately, a recent study by the Indian
Council of Medical Research (ICMR) involving 98 people, 18 of whom had
inadvertently received Covishield as the first dose and Covaxin as the second
in Uttar Pradesh, showed that combining these two COVID-19 vaccines elicited
better immunogenicity than two doses of the same vaccine. Read
More
Comments
Post a Comment